What Bonraybio does

Bonraybio Co., Ltd. (邦睿生技股份有限公司) is a Taiwan-based medical device company specializing in male infertility diagnostic solutions under the LensHooke brand. Founded in 2016 by a team with more than 10 years of medical instrument development experience, the company is headquartered in Taichung City, Taiwan, with wholly-owned subsidiary offices in Ontario, California (USA) and Ziyang City, Sichuan (China), and completed its IPO on the Taiwan Stock Exchange (ticker 6955) in December 2024 following a 2023 Emerging Stock Board (興櫃) listing. The company targets IVF centers, fertility clinics, andrology laboratories, and urology practices across more than 18 countries, with a particular focus on the historically underserved male-factor infertility diagnostic workflow.

The company's product portfolio forms an integrated platform called MITS (Male Infertility Total Solution), combining three automated semen analyzers (X1 PRO, X3 PRO, X12 PRO), two sperm DNA fragmentation test kits (R10 Plus, R11 Plus), two sperm separation devices (CA0, CA1), and the C-KUP liquefaction test cup. Core technology is AI-powered computer vision applied to microscopic sperm image analysis, paired with novel sperm chromatin dispersion detection methods; the X12 PRO received FDA 510(k) clearance in June 2025 as the world's first FDA-approved sperm DNA fragmentation test, and CA0/CA1 received FDA approval in October 2022. The IP portfolio comprises 111 global patent applications (93 granted, 18 pending) and 70 registered trademarks across Taiwan, China, the USA, and Europe.

Bonraybio monetizes through a hybrid model combining capital equipment sales (instruments placed at IVF labs and clinics) with recurring consumable reagent sales (R10/R11 Plus test kits tied to installed analyzers), supplemented by aftermarket service. Pricing is quote-based and not publicly disclosed; all sales are executed via an extensive distributor network, with Hamilton Thorne (USA) and nal von minden GmbH (Germany) as core channel partners alongside regional distributors across Italy, South Korea, Thailand, Vietnam, Israel, the UAE, Turkey, and others. The company is heavily event-driven, participating in major reproductive medicine exhibitions (MEDICA, ASRM, ESHRE, CSRM) and conducting global MITS hands-on workshops to train distributors and engage embryologists and andrologists.

Name

Bonraybio

Legal name

邦睿生技股份有限公司

Website

https://bonraybio.com

Company type

Public

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

Bonraybio Co., Ltd. (Taiwan) develops AI-powered male infertility diagnostic solutions under the LensHooke brand — automated semen analyzers, sperm DNA fragmentation test kits, and sperm separation devices — serving IVF clinics, fertility centers, and andrology laboratories across 18+ countries.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Devices — Andrology / Male Infertility

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)

Keywords

• Automated semen analysis
• Sperm DNA fragmentation testing
• Male infertility diagnostics
• IVF laboratory equipment
• Andrology diagnostic devices

Headquarters

HQ city

Taichung

HQ country

Taiwan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Sale of automated semen analysis instruments (X1 PRO, X3 PRO, X12 PRO) and sperm separation devices (CA0, CA1). These are capital equipment purchases made by IVF laboratories, fertility clinics, and hospitals.
2. Consumable Reagent Kits: Recurring sales of sperm DNA fragmentation test kits (R10 Plus, R11 Plus) and other reagents. These consumables are used with the company's instruments and represent a recurring revenue stream tied to testing volume.
3. Aftermarket Services and Support: Technical support, maintenance services, and potentially software updates for installed base of instruments in laboratories worldwide.

Pricing tiers

Go-to-market motion2 records

Distribution channels9 records

Marketing channels6 records

Core offering

Bonraybio manufactures and sells AI-powered medical diagnostic devices and consumables under the LensHooke brand to provide a complete Male Infertility Total Solution. Its core offerings include automated semen quality analyzers (LensHooke X1 PRO, X3 PRO, X12 PRO), sperm DNA fragmentation test kits (R10 Plus, R11 Plus), sperm separation devices (CA0, CA1) used in IVF preparation, and the C-KUP liquefaction test cup. The portfolio is sold to IVF centers, fertility clinics, andrology laboratories, and urology practices globally through distributors and direct channels.

Product overview

Bonraybio (邦睿生技) offers the LensHooke brand of male infertility diagnostic solutions, consisting of a platform-plus-modules architecture called MITS (Male Infertility Total Solution). The portfolio includes three automated semen analysis systems (X1 PRO, X3 PRO, X12 PRO), two sperm DNA fragmentation test kits (R10 Plus, R11 Plus), and two sperm separation devices (CA0, CA1), plus the C-KUP liquefaction test cup. These products work together to provide comprehensive male fertility testing from basic semen analysis to advanced DNA fragmentation assessment and sperm selection for assisted reproduction.

Differentiator

Problem solved

Functional benefit

Brands

• LensHooke: Brand for male infertility total solutions including semen analysis systems, sperm DNA fragmentation tests, and sperm separation devices
• LensHooke MITS

Products and services

• LensHooke X1 PRO Semen Quality Analyzer Fully-automatic AI-assisted semen quality analyzer for IVF clinics and andrology labs; provides rapid, simple, and standardized examination of pH, sperm concentration, motility, and morphology. Installed in 100+ US labs and clinics since 2019 via Hamilton Thorne.
• LensHooke X3 PRO Semen Quality Analyzer Automated semen quality analyzer with an easy-to-use design and high-precision features for sperm analysis; targeted at clinical andrology labs and fertility clinics needing reliable routine semen inspection.
• LensHooke X12 PRO Fully-Automatic Sperm Analysis System Fully-automatic sperm analysis system combining AI-powered semen quality analysis with sperm DNA fragmentation testing on a single platform; intended for IVF clinics, andrology labs, and research institutions performing advanced male fertility diagnostics.
• LensHooke R10 Plus Sperm DNA Fragmentation Rapid Test Kit Consumable reagent kit using sperm chromatin dispersion technology for rapid, accurate assessment of sperm DNA fragmentation; used by fertility clinics and andrology labs that do not have access to flow cytometry.
• LensHooke R11 Plus Sperm DNA Fragmentation Test Kit Reagent kit designed to detect sperm DNA double-strand breaks (DSB) — a marker scientifically correlated with miscarriage and embryo aneuploidy; positioned as the only commercially available reagent kit for DSB detection.
• LensHooke CA0 Sperm Separation Device Sperm separation device using live motile sorting technology for IVF preparation; delivers consistent sperm selection efficiency for both normal and abnormal semen samples without centrifugation. Clinically adopted in leading hospitals including centers in Chengdu, China.
• LensHooke CA1 Sperm Separation Device Variant of the CA0 sperm separation device providing centrifugation-free sperm selection for fertility treatments; part of the LensHooke live motile sorting product line.
• C-KUP Liquefaction Test Cup Single-use liquefaction test cup designed to avoid cross-infection risks during semen testing, including coronavirus-related contamination concerns in semen samples; used as a consumable with the LensHooke analyzer workflow.

Quantifiable outcome

• DFI minimized in samples processed by CA0
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core, major and minor.

• Hamilton Thorne Inc.coreChannel Partner/ Reseller/ Distributor · 1 January 2019Exclusive US distributor for LensHooke products including X1 PRO semen analysis system, X12 PRO, and CA0 sperm separation device. Partnership established from 2019. Hamilton Thorne assists Bonraybio with US market exhibitions including ASRM annual meetings. Over 100 US labs and clinics have adopted LensHooke products through this channel.
• nal von minden GmbHcoreChannel Partner/ Reseller/ DistributorGermany distributor for LensHooke Male Infertility Total Solution portfolio including X1 PRO, R10, X12 PRO, and CA0. Organized MITS workshop in Göttingen, Germany and AGRBM congress participation. Over 80 IVF centers and 300 embryologists engaged through German market activities.
• Al-RAD LtdmajorChannel Partner/ Reseller/ DistributorIsrael distributor conducting LensHooke marketing events including visits to IVF centers and hospitals for product demonstrations. Received positive feedback on X1 PRO and CA0 products.
• Al Fahim Healthcare Solutions LLCmajorChannel Partner/ Reseller/ DistributorUAE distributor participating in Medlab Middle East exhibition with Bonraybio. Booth Z6.H20 showcasing LensHooke product line.
• Fertilife s.r.l.majorChannel Partner/ Reseller/ DistributorItaly distributor for LensHooke products. Organized successful MITS workshop in Milan with 12 reproductive doctors and embryologists. Supported ESHRE 2024 participation.
• CNC BiotechmajorChannel Partner/ Reseller/ DistributorSouth Korea distributor co-organizing Korean Society reproductive medicine conference and MITS workshops at CNC headquarters. Strong agreement on future trends including sperm DNA fragmentation testing and centrifugation-free sperm separation.
• Investment Technology Solutions Company LimitedmajorChannel Partner/ Reseller/ DistributorVietnam distributor, one of the leading IVF companies in Vietnam. Organized MITS seminar at Vinmec Hospital Hanoi with 30 doctors and embryologists. Showcased X1 PRO, R10/X12 PRO, and CA0 products.
• A.P.TEC (Thailand) Co., Ltd.majorChannel Partner/ Reseller/ DistributorThailand distributor co-organizing workshop with ThaiSRM (Thai Society for Reproductive Medicine) and Siam Fertility Clinic. Focused on IUI treatment applications.
• ARKİM MEDİKALminorChannel Partner/ Reseller/ DistributorTurkey distributor participating in expoMED Eurasia exhibition. Over 100 doctors and visitors engaged at booth.
• First Capital Securities Corporation (第一金證券)minorOthersStock affairs agent for listed company shareholder services. Contact: 02-2563-5711
• Toliopoulos DiagnosticsminorChannel Partner/ Reseller/ DistributorSupport partner for ESHRE 2024 exhibition in Amsterdam, Netherlands.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Hamilton Thorne: Direct competitor and simultaneously Bonraybio's exclusive US distributor for LensHooke products. Hamilton Thorne offers CASA (computer-assisted sperm analysis) systems, laser systems, and consumables for the IVF and andrology markets, overlapping directly with Bonraybio's X1/X3/X12 PRO analyzers and CA0/CA1 separation devices in target customer workflows.
• Microptic: Spanish developer of the Sperm Class Analyzer (SCA) CASA system for automated sperm analysis. Direct technology competitor to Bonraybio's X1 PRO and X3 PRO semen analyzers, serving andrology labs and IVF centers globally.
• Genea Biomedx: Develops and commercializes instruments and consumables for IVF laboratories, including sperm preparation and embryo culture systems. Comparable to Bonraybio as a focused ART device vendor targeting clinical fertility workflows with both hardware and consumables.
• Esco Medical: Manufactures IVF and ART equipment including time-lapse incubators and ART workstations. Comparable as an Asia-based (Singapore) medical device specialist serving the same global IVF clinic and embryology lab customer base as Bonraybio.

Broad incumbents

• Vitrolife: Global IVF/ART solutions provider offering media, consumables, and time-lapse incubation systems. Overlaps with Bonraybio's reproductive medicine customer base (IVF clinics, andrology labs) though Vitrolife's portfolio spans female-factor ART rather than male-factor diagnostics.
• FUJIFILM Irvine Scientific: Supplies cell culture media, reagents, and ART consumables to IVF clinics. Comparable as a global ART consumables leader sharing Bonraybio's clinical fertility customer base, though focused on female-factor and culture media versus Bonraybio's male-factor diagnostics.
• LabCorp: Large clinical laboratory network with andrology testing services. Represents an adjacent incumbent that could either become a customer for automated semen analysis platforms or a competitive clinical lab alternative for referring physicians.
• Danaher (Leica Microsystems / Beckman Coulter): Through Leica Microsystems and Beckman Coulter, Danaher supplies microscopy and flow cytometry platforms used in andrology research and diagnostics. Could integrate competing sperm analysis capabilities or supply flow cytometer-based DNA fragmentation testing as an alternative to Bonraybio's reagent kits.
• CooperSurgical (CooperCompanies): Major fertility and women's health franchise offering ART media, devices, and genomics services including PGT. Shares Bonraybio's IVF clinic and andrology lab customer segments at scale across global markets.

Emerging players

• SciNote / Sperm Tracker (Andrology Solutions): Smaller software- and instrument-focused entrants in the automated semen analysis and sperm quality assessment market. Comparable to Bonraybio as niche specialists attempting to digitize and standardize andrology workflows with emerging clinical adoption.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/bonraybio
• Xx.com/bonraybio

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bonraybio